COLLINO, Massimo
 Distribuzione geografica
Continente #
NA - Nord America 12.034
EU - Europa 7.436
AS - Asia 4.091
SA - Sud America 165
OC - Oceania 82
AF - Africa 53
Continente sconosciuto - Info sul continente non disponibili 35
Totale 23.896
Nazione #
US - Stati Uniti d'America 11.846
CN - Cina 2.525
IT - Italia 1.847
IE - Irlanda 1.021
SE - Svezia 802
DE - Germania 660
FR - Francia 507
GB - Regno Unito 480
UA - Ucraina 451
FI - Finlandia 428
DK - Danimarca 378
VN - Vietnam 339
KR - Corea 300
PL - Polonia 268
JP - Giappone 226
SG - Singapore 181
CA - Canada 118
IN - India 115
HK - Hong Kong 112
AT - Austria 103
BR - Brasile 89
ES - Italia 87
TW - Taiwan 76
AU - Australia 75
NL - Olanda 68
BE - Belgio 67
TR - Turchia 63
MX - Messico 58
RU - Federazione Russa 53
RO - Romania 47
CH - Svizzera 34
EU - Europa 33
GR - Grecia 28
NO - Norvegia 25
AR - Argentina 23
EG - Egitto 22
IR - Iran 21
CL - Cile 20
IL - Israele 20
HU - Ungheria 17
TH - Thailandia 17
CZ - Repubblica Ceca 16
CO - Colombia 15
MY - Malesia 14
PH - Filippine 14
ID - Indonesia 13
SN - Senegal 13
PT - Portogallo 12
UZ - Uzbekistan 11
SA - Arabia Saudita 10
PE - Perù 8
NZ - Nuova Zelanda 7
MO - Macao, regione amministrativa speciale della Cina 6
SI - Slovenia 6
BA - Bosnia-Erzegovina 5
BD - Bangladesh 5
DZ - Algeria 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
BO - Bolivia 4
IQ - Iraq 4
KZ - Kazakistan 4
PK - Pakistan 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
BZ - Belize 3
CU - Cuba 3
EC - Ecuador 3
HN - Honduras 3
A1 - Anonimo 2
AL - Albania 2
AM - Armenia 2
HR - Croazia 2
JO - Giordania 2
KE - Kenya 2
LU - Lussemburgo 2
PR - Porto Rico 2
BJ - Benin 1
BY - Bielorussia 1
CY - Cipro 1
EE - Estonia 1
IM - Isola di Man 1
KH - Cambogia 1
KM - Comore 1
LI - Liechtenstein 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
MW - Malawi 1
NG - Nigeria 1
PY - Paraguay 1
SC - Seychelles 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
VE - Venezuela 1
Totale 23.896
Città #
Ann Arbor 1.470
Chandler 1.390
Dublin 1.014
Beijing 970
Fairfield 885
Houston 617
Ashburn 566
Torino 505
Wilmington 486
Woodbridge 416
Seattle 371
Dearborn 334
Pisa 332
Jacksonville 324
Villeurbanne 318
Cambridge 309
Nyköping 275
Medford 264
Princeton 261
Redwood City 249
Warsaw 244
Dong Ket 237
Shanghai 168
Turin 133
Nanjing 129
Singapore 125
Guangzhou 123
London 115
Frankfurt am Main 106
Vienna 87
Fremont 84
Boston 78
San Diego 74
Milan 71
Boardman 70
Wuhan 59
Hangzhou 57
Xian 53
Taipei 49
Hefei 48
Chengdu 47
Brussels 44
Tokyo 44
Helsinki 42
New York 42
Zhengzhou 41
Changsha 40
Norwalk 40
Phoenix 40
Rome 37
Washington 36
Chongqing 35
Lappeenranta 35
Toronto 35
Hong Kong 34
Hebei 32
Seoul 32
Jena 30
Shenyang 30
Ottawa 27
Silver Spring 26
Jinan 24
Munich 24
Central District 23
Central 22
Falls Church 22
Aachen 21
Paris 21
Shenzhen 21
Verona 21
Fort Worth 20
Osaka 20
Los Angeles 19
Pune 19
Berlin 18
Kunming 18
Upper Marlboro 18
Tianjin 17
Harbin 16
Oslo 16
San Francisco 16
Eschweiler 15
Santiago 15
São Paulo 15
Bari 14
Changchun 14
Düsseldorf 14
Amsterdam 13
Barcelona 13
Madrid 13
Mountain View 13
Nanchang 13
Pittsburgh 13
Ankara 12
Des Moines 12
Hamburg 12
Nuremberg 12
Chennai 11
Fuzhou 11
Guiyang 11
Totale 14.877
Nome #
Metaflammation: tissue-specific alterations of the NLRP3 inflammasome platform 1.224
Artesunate Protects Against the Organ Injury and Dysfunction Induced by Severe Hemorrhage and Resuscitation 540
Novel Synthetic, Host-defense Peptide Protects Against Organ Injury/Dysfunction in a Rat Model of Severe Hemorrhagic Shock 484
Targeting endothelial metaflammation to counteract diabesity cardiovascular risk: Current and perspective therapeutic options 401
Stable Oxidative Cytosine Modifications Accumulate in Cardiac Mesenchymal Cells from Type2 Diabetes Patients: Rescue by alpha Ketoglutarate and TET-TDG Functional Reactivation 395
Fructose liquid and solid formulations differently affect gut integrity, microbiota composition and related liver toxicity: a comparative in vivo study 309
Maladaptive Modulations of NLRP3 Inflammasome and Cardioprotective Pathways Are Involved in Diet-Induced Exacerbation of Myocardial Ischemia/Reperfusion Injury in Mice 305
Pharmacological inhibition of NLRP3 inflammasome attenuates myocardial ischemia/reperfusion injury by activation of RISK and mitochondrial pathways 303
Combined untargeted and targeted fingerprinting by comprehensive two-dimensional gas chromatography: revealing fructose-induced changes in mice urinary metabolic signatures 299
Advanced glycation end products as biomarkers in systemic diseases: Premises and perspectives of salivary advanced glycation end products 289
PPARgamma stimulation promotes mitochondrial biogenesis and prevents glucose deprivation-induced neuronal cell loss 287
Reversal of the deleterious effects of chronic dietary HFCS-55 intake by PPAR- agonism correlates with impaired NLRP3 inflammasome activation 285
A non-erythropoietic peptide derivative of erythropoietin decreases susceptibility to diet-induced insulin resistance in mice 268
Is NLRP3 inflammasome a new pharmacological target in myocardial ischemia/reperfusion injury? 265
Accumulation of Advanced Glycation End-Products and Activation of the SCAP/SREBP Lipogenetic Pathway Occur in Diet-Induced Obese Mouse Skeletal Muscle. 264
Advanced glycation end-products promote hepatosteatosis by interfering with SCAP-SREBP pathway in fructose drinking mice 253
Targeting the NLRP3 inflammasome to reduce diet-induced metabolic abnormalities in mice 234
Resolvin D1 Attenuates the Organ Injury Associated With Experimental Hemorrhagic Shock 220
DUAL SECOND DIMENSION COLUMN-DUAL DETECTION IN TWO-DIMENSIONAL COMPREHENSIVE GAS CHROMATOGRAPHY (GC×2GC-MS/FID): INCREASED INFORMATION IN OPTIMIZED SEPARATION CONDITIONS IN METABOLOMICS 217
SALIVAGE – EU JPI Project The “form” makes the difference: comprehensive two‐dimensional gas chromatography as highly informative fingerprinting tool to study the impact of fructose formulation on mice’s microbiota and its volatile metabolome signatures 217
Exacerbation of myocardial ischemia/reperfusion injury induced by high-fat-high-fructose (HFHF) diet: Role of NLRP3 inflammasome 214
IκB Kinase Inhibitor Attenuates Sepsis-Induced Cardiac Dysfunction in CKD 213
High Sugar Intake and Development of Skeletal Muscle Insulin Resistance and Inflammation in Mice: A Protective Role for PPAR- δ Agonism. 213
Carnosine analogues containing NO-donor substructures: Synthesis, physico-chemical characterization and preliminary pharmacological profile 211
Acute treatment with bone marrow-derived mononuclear cells attenuates the organ injury/dysfunction induced by hemorrhagic shock in the rat. 210
Variability in myosteatosis and insulin resistance induced by high-fat diet in mouse skeletal muscles. 205
Peroxisome proliferator-activated receptor β/δ agonism protects the kidney against ischemia/reperfusion injury in diabetic rats. 197
Chronic administration of saturated fats and fructose differently affect SREBP activity resulting in different modulation of Nrf2 and Nlrp3 inflammasome pathways in mice liver 190
Exploring extra dimensions to capture saliva metabolite fingerprints from metabolically healthy and unhealthy obese patients by comprehensive two-dimensional gas chromatography featuring Tandem Ionization mass spectrometry 188
Fructose-derived advanced glycation end-products induce a negative crosstalk between lipogenesis and muscle reprogramming in mice through SREBP-1c 186
Urinary metabolic fingerprinting of mice with diet-induced metabolic derangements by parallel dual secondary column-dual detection two-dimensional comprehensive gas chromatography 183
Neuronal nitric oxide synthase is involved in vascular hyporeactivity and multiple organ dysfunction associated with hemorrhagic shock 180
Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis 180
Pyridoxamine prevents diet-induced insulin resistance through the regulation of ceramide/sphingosine/sphingosine-1-phosphate equilibrium in mice liver 178
Advanced Glycation End Products Inhibition Restores Sphingolipid Rheostat in Mice Liver and Prevents Diet-Induced Insulin Resistance 177
Fructose-derived advanced glycation end-products drive lipogenesis and skeletal muscle reprogramming via SREBP-1c dysregulation in mice 174
Overexpression of histamine H4 receptors in the kidney of diabetic rat 173
The Role of PPARβ/δ in the Management of Metabolic Syndrome and its Associated Cardiovascular Complications. 171
High-fructose intake as risk factor for neurodegeneration: Key role for carboxy methyllysine accumulation in mice hippocampal neurons 168
Erythropoietin attenuates acute kidney dysfunction in murine experimental sepsis by activation of the β-common receptor. 167
Flipping the molecular switch for innate protection and repair of tissues: Long-lasting effects of a non-erythropoietic small peptide engineered from erythropoietin. 167
Development of Standard Operating Protocols for the Optimization of Cannabis-Based Formulations for Medical Purposes 162
Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: effects of the PPAR-alpha agonist WY14643 160
Acute treatment with relaxin protects the kidney against ischaemia/reperfusion injury. 155
Altered hepatic sphingolipid metabolism in insulin resistant mice: Role of advanced glycation endproducts 155
Effects of a semi-synthetic N-,O-sulfated glycosaminoglycan K5 polysaccharide derivative in a rat model of cerebral ischaemia/reperfusion injury 154
Fructose-Derived Advanced Glycation End-Products Evoke Skeletal Muscle Damage in Mice by Multiple Interference with SCAP-SREBP Pathway 147
Cannabis FM2: optimization and standardization of galenic preparations. 147
A nonerythropoietic peptide analog of erythropoietin decreases susceptibility to diet-induced insulin resistance 146
Artesunate protects against the organ injury and dysfunction induced by severe hemorrhage and resuscitation 145
Effects of Vitamin D on insulin resistance and myosteatosis in diet-induced obese mice 142
Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes 140
Identification of Annexina1 as an endogenous regulator of RhoA, and its role in the pathophysiology and experimental therapy of type-2 diabetes 139
The NLRP3 Inflammasome as a Novel Player of the Intercellular Crosstalk in Metabolic Disorders. 137
Effects of exogenous dietary advanced glycation end products on the cross-talk mechanisms linking microbiota to metabolic inflammation 137
The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials 136
Sviluppo di protocolli operativi standard per l’ottimizzazione di preparazioni galeniche allestite con cannabis “FM2” 132
The Anti-Malarial Drug Artesunate Attenuates Cardiac Injury in a Rodent Model of Myocardial Infarction 128
Elevation of serum sphingosine-1-phosphate attenuates impaired cardiac function in experimental sepsis 127
Toxicological impact of high fructose intake on gut microbiota and liver/intestine integrity: Any differences between solid and liquid formulations? 124
A Nitric Oxide-Donor Furoxan Moiety Improves the Efficacy of Edaravone against Early Renal Dysfunction and Injury Evoked by Ischemia/Reperfusion 122
Advanced glycation end products and their related signaling cascades in adult survivors of childhood Hodgkin lymphoma: A possible role in the onset of late complications 122
The AGEs inhibitor pyridoxamine prevents kidney injury and dysfunction in mice fed high-fat high-fructose diet 119
The synthetic antimicrobial peptide 19-2.5 attenuates septic cardiomyopathy and prevents down-regulation of SERCA2 in polymicrobial sepsis 119
Inflammatory signaling and insulin resistance caused by sugar intake: modulation by PPAR-δ agonism 117
Bruton's Tyrosine Kinase Inhibition Attenuates the Cardiac Dysfunction Caused by Cecal Ligation and Puncture in Mice 117
Protective Effects of Pyridoxamine Supplementation in the Early Stages of Diet-Induced Kidney Dysfunction 115
Delayed Administration of Pyroglutamate Helix B Surface Peptide (pHBSP), a Novel Nonerythropoietic Analog of Erythropoietin, Attenuates Acute Kidney Injury. 115
Effects of High Intakes of Fructose and Galactose, with or without Added Fructooligosaccharides, on Metabolic Factors, Inflammation, and Gut Integrity in a Rat Model 115
Linagliptin Attenuates the Cardiac Dysfunction Associated With Experimental Sepsis in Mice With Pre-existing Type 2 Diabetes by Inhibiting NF-κB 115
Microparticles released as a consequence of lipid-induced toxicity promote NLRP3 inflammasome activation in HepG2 cells. 113
Baricitinib counteracts metaflammation, thus protecting against diet-induced metabolic abnormalities in mice 111
Angiotensin II induces tumor necrosis factor-alpha expressionand release from cultured human podocytes 110
The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway 110
Erythropoietin in the intensive care unit: beyond treatment of anemia. 108
Cardiac Epi-Metabolic Signature Revealed by Integrated Omics Approach in Diabetic Patients: Rescue by Active DNA Demethylation via TET-TDG Complex Reactivation 105
Dopexamine can attenuate the inflammatory response and protect against organ injury in the absence of significant effects on hemodynamics or regional microvascular flow. 104
Effects of anti-inflammatory [1, 2, 4]triazolo[4, 3-a] [1, 8]naphthyridine derivatives on human stimulated PMN and endothelial cells: an in vitro study 99
Immunotossicologia 94
Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation 94
Effects of empagliflozin in a murine model of diet-induced insulin resistance: A role for NLRP3 inflammasome inhibition? 94
A non-erythropoietic peptide that mimicks the 3D structure of erythropoietin reduces organ injury/dysfunction and inflammation in experimental hemorrhagic shock. 92
Inhibition of Bruton's TK regulates macrophage NF-κB and NLRP3 inflammasome activation in metabolic inflammation 92
Cold ischemic injury is reduced by the mGluR5 negative allosteric modulator MPEP in rat livers from cardiac death donors 92
Modulazione farmacologica della patologia ischemica: studio degli effetti dei ligandi di PPAR 91
Microparticles released by fat-laden cells activate in a paracrine way NLRP3 inflammasome in both HepG2 cells and macrophages. 91
‘Preconditioning’ with Low Dose Lipopolysaccharide Aggravates the Organ Injury / Dysfunction Caused by Hemorrhagic Shock in Rats 91
The cardiac dysfunction caused by sepsis in animals with chronic kidney disease is attenuated by inhibiting I kappa B kinase 91
Advanced glycation end products and chronic inflammation in adult survivors of childhood leukemia treated with hematopoietic stem cell transplantation 91
Transient expression of reck under hepatic ischemia/reperfusion conditions is associated with mapk signaling pathways 90
Reduced Susceptibility to Sugar-Induced Metabolic Derangements and Impairments of Myocardial Redox Signaling in Mice Chronically Fed with D-Tagatose when Compared to Fructose 89
Erythropoietin attenuates cardiac dysfunction in experimental sepsis in mice via activation of the β-common receptor. 87
Activation of Ppar-beta/delta attenuates mycardial ischemia/reperfusion injury in the rat 86
Advanced Glycation End-Products Promote Lipogenesis in Liver of Fructose-Drinking Mice 85
Beneficial effect of prolonged heme oxygenase 1 activation in a rat model of chronic heart failure. 85
Mediators of Interorgan Crosstalk in Metabolic Inflammation 85
Dietary advanced glycation endproducts in the mechanisms linking proteins glycosylation pattern, microbiota, and metabolic inflammation 85
Gender dimorphism of the cardiac dysfunction in murine sepsis: signalling mechanisms and age-dependency. 84
Microparticles released by fat-laden cells activate in a paracrine way NLRP3 inflammasome in both HepG2 cells and macrophages. 84
RvE1 Attenuates Polymicrobial Sepsis-Induced Cardiac Dysfunction and Enhances Bacterial Clearance 84
Totale 17.710
Categoria #
all - tutte 60.918
article - articoli 0
book - libri 0
conference - conferenze 19.025
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.943


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019225 0 0 0 0 0 0 0 0 0 0 0 225
2019/20204.044 168 140 183 660 345 509 427 343 416 344 275 234
2020/20213.734 253 225 203 279 369 285 268 256 360 335 232 669
2021/20224.080 293 288 278 352 270 227 261 312 202 305 687 605
2022/20234.582 491 347 136 436 390 1.077 328 292 637 120 183 145
2023/20241.969 250 285 121 112 179 245 117 137 41 179 247 56
Totale 24.932